Vivance Unveils New Brand Identity
Vivance, a trailblazer in the field of kidney care, has recently transformed its name from AWAK Technologies. This rebranding marks a significant milestone in the company’s journey, indicative of its evolving mission and dedication to improving kidney health. The name Vivance reflects vitality and progress, aligning perfectly with the company’s vision to innovate within this critical healthcare niche.
Innovation and Patient Care at the Core
The inception of Vivance stemmed from groundbreaking technological advancements in kidney care, specifically the development of the Automated Wearable Artificial Kidney (AWAK) device. This useful innovation not only eases the burdens faced by patients but also provides an effective solution for home dialysis, allowing individuals to manage their health more conveniently.
The Vision of the Leadership
Suresha Venkataraya, the CEO of Vivance, encapsulated the essence of this rebranding, stating that it symbolizes both their journey and future aspirations. Under his leadership, the company is expanding its offerings to include cost-effective home modalities and digital tools designed to enhance patient connection and health management. This progressive approach aims to empower patients with the resources needed to manage their health comfortably at home.
Strategic Goals and Future Developments
The Chairman of Vivance, Abel Ang, articulated a compelling vision for the company’s future. He expresses excitement about what this new chapter will bring, particularly with the support of two significant device designations from regulatory authorities. As they pivot towards a patient-centric focus in dialysis technology, Vivance is set to redefine patient care and accessibility in kidney health management.
A Promise to Innovate
Moving forward as Vivance, the company is committed to enhancing its brand strategy and product offerings. Their innovative wearable dialysis device is currently in clinical trials, showing promising developments that could drastically alter the landscape of kidney care. Complementary technologies such as point-of-care fluid generation systems, remote monitoring applications, and AI predictive models are already in advanced stages of research. These solutions promise to move seamlessly into clinical phases, aiming to make a tangible difference in the lives of those with kidney disease.
About Vivance
Vivance, previously known as AWAK Technologies, stands as a pioneering entity in medical technology focused on kidney care. With its headquarters in Singapore and additional locations in Los Angeles and Bengaluru, the company is steadfast in its mission to deliver innovative solutions for patients suffering from kidney ailments. Their commitment extends beyond just medical technology; it reflects a broader aim to improve the experiences and outcomes for patients and their caregivers.
Frequently Asked Questions
What is the significance of the name change to Vivance?
The name Vivance embodies the essence of vitality and progress, reflecting the company's mission to innovate and improve kidney health care.
What products are associated with Vivance?
Vivance's key products include the Automated Wearable Artificial Kidney and various complementary digital health solutions aimed at enhancing patient care.
How does Vivance's technology improve patient care?
The technology provided by Vivance allows patients to manage their treatment at home, leading to better health outcomes and quality of life.
What future developments can we expect from Vivance?
Vivance is progressing through clinical trials for its wearable dialysis device and is working on innovative technologies for kidney care.
Where is Vivance headquartered?
Vivance is headquartered in Singapore, with additional offices in the United States and India, facilitating its global reach in medical technology.
